vs
CITIZENS FINANCIAL SERVICES INC（CZFS）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
CITIZENS FINANCIAL SERVICES INC的季度营收约是STANDARD BIOTOOLS INC.的1.5倍（$29.6M vs $19.6M），CITIZENS FINANCIAL SERVICES INC净利率更高（35.4% vs -177.4%，领先212.8%），CITIZENS FINANCIAL SERVICES INC同比增速更快（13.0% vs -11.5%），CITIZENS FINANCIAL SERVICES INC自由现金流更多（$35.2M vs $-23.1M），过去两年CITIZENS FINANCIAL SERVICES INC的营收复合增速更高（6.9% vs -12.2%）
公民金融集团是一家美国银行控股公司，总部位于罗得岛州普罗维登斯。集团旗下拥有公民银行（Citizens Bank, N.A.），业务覆盖美国康涅狄格、特拉华、佛罗里达等十余个州及华盛顿哥伦比亚特区。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CZFS vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.6M | $19.6M |
| 净利润 | $10.5M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 44.2% | -168.5% |
| 净利率 | 35.4% | -177.4% |
| 营收同比 | 13.0% | -11.5% |
| 净利润同比 | 31.3% | -28.8% |
| 每股收益（稀释后） | $2.17 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $29.6M | — | ||
| Q3 25 | $29.0M | $19.6M | ||
| Q2 25 | $27.3M | $21.8M | ||
| Q1 25 | $26.4M | $40.8M | ||
| Q4 24 | $26.2M | — | ||
| Q3 24 | $25.1M | $22.1M | ||
| Q2 24 | $24.6M | $22.5M | ||
| Q1 24 | $25.9M | $45.5M |
| Q4 25 | $10.5M | — | ||
| Q3 25 | $10.0M | $-34.7M | ||
| Q2 25 | $8.5M | $-33.5M | ||
| Q1 25 | $7.6M | $-26.0M | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $7.5M | $-26.9M | ||
| Q2 24 | $5.3M | $-45.7M | ||
| Q1 24 | $7.0M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | 44.2% | — | ||
| Q3 25 | 42.6% | -168.5% | ||
| Q2 25 | 38.1% | -118.1% | ||
| Q1 25 | 35.5% | -80.8% | ||
| Q4 24 | 37.2% | — | ||
| Q3 24 | 36.9% | -120.9% | ||
| Q2 24 | 25.9% | -134.5% | ||
| Q1 24 | 32.8% | -132.2% |
| Q4 25 | 35.4% | — | ||
| Q3 25 | 34.5% | -177.4% | ||
| Q2 25 | 31.0% | -153.7% | ||
| Q1 25 | 28.8% | -63.8% | ||
| Q4 24 | 30.5% | — | ||
| Q3 24 | 30.0% | -122.0% | ||
| Q2 24 | 21.4% | -203.3% | ||
| Q1 24 | 27.1% | -70.6% |
| Q4 25 | $2.17 | — | ||
| Q3 25 | $2.09 | $-0.09 | ||
| Q2 25 | $1.76 | $-0.09 | ||
| Q1 25 | $1.60 | $-0.07 | ||
| Q4 24 | $1.64 | — | ||
| Q3 24 | $1.57 | $-0.07 | ||
| Q2 24 | $1.10 | $-0.12 | ||
| Q1 24 | $1.48 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.3M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $338.1M | $399.7M |
| 总资产 | $3.1B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $34.3M | — | ||
| Q3 25 | $31.1M | $129.4M | ||
| Q2 25 | $49.5M | $158.6M | ||
| Q1 25 | $36.8M | $150.9M | ||
| Q4 24 | $42.2M | — | ||
| Q3 24 | $36.8M | $210.6M | ||
| Q2 24 | $38.4M | $269.8M | ||
| Q1 24 | $29.6M | $287.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
| Q4 25 | $338.1M | — | ||
| Q3 25 | $327.7M | $399.7M | ||
| Q2 25 | $313.7M | $424.5M | ||
| Q1 25 | $308.3M | $454.6M | ||
| Q4 24 | $299.7M | — | ||
| Q3 24 | $298.7M | $489.3M | ||
| Q2 24 | $286.5M | $510.3M | ||
| Q1 24 | $282.7M | $577.3M |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.1B | $539.6M | ||
| Q2 25 | $3.0B | $557.0M | ||
| Q1 25 | $3.0B | $579.6M | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $3.0B | $681.5M | ||
| Q2 24 | $2.9B | $708.7M | ||
| Q1 24 | $2.9B | $777.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.5M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $35.2M | $-23.1M |
| 自由现金流率自由现金流/营收 | 119.0% | -118.1% |
| 资本支出强度资本支出/营收 | 4.4% | 4.5% |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $53.8M | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $36.5M | — | ||
| Q3 25 | $2.9M | $-22.2M | ||
| Q2 25 | $6.0M | $-20.7M | ||
| Q1 25 | $10.9M | $-30.3M | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | $6.2M | $-27.9M | ||
| Q2 24 | $3.0M | $-39.0M | ||
| Q1 24 | $13.5M | $-62.5M |
| Q4 25 | $35.2M | — | ||
| Q3 25 | $2.7M | $-23.1M | ||
| Q2 25 | $5.5M | $-22.6M | ||
| Q1 25 | $10.4M | $-35.3M | ||
| Q4 24 | $31.9M | — | ||
| Q3 24 | $5.6M | $-30.1M | ||
| Q2 24 | $2.9M | $-41.0M | ||
| Q1 24 | $13.4M | $-63.3M |
| Q4 25 | 119.0% | — | ||
| Q3 25 | 9.4% | -118.1% | ||
| Q2 25 | 20.1% | -103.6% | ||
| Q1 25 | 39.2% | -86.6% | ||
| Q4 24 | 121.6% | — | ||
| Q3 24 | 22.3% | -136.4% | ||
| Q2 24 | 11.8% | -182.2% | ||
| Q1 24 | 51.5% | -138.9% |
| Q4 25 | 4.4% | — | ||
| Q3 25 | 0.5% | 4.5% | ||
| Q2 25 | 1.8% | 8.7% | ||
| Q1 25 | 2.2% | 12.4% | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | 10.2% | ||
| Q2 24 | 0.5% | 8.6% | ||
| Q1 24 | 0.4% | 1.7% |
| Q4 25 | 3.49× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.16× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 1.92× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CZFS
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
